Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL-variant

被引:0
|
作者
Hoff, Fieke W. [1 ]
Griffen, Ti'ara L. [2 ]
Qiu, Yihua [3 ]
Kornblau, Steven M. [3 ]
机构
[1] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA
[2] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA USA
[3] UT MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Box 448, Houston, TX 77030 USA
来源
EJHAEM | 2022年 / 3卷 / 04期
关键词
CLL; hairy cell leukaemia; leukemia; EXPRESSION; MUTATIONS;
D O I
10.1002/jha2.558
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Classical hairy cell leukemia (HCL-c) and HCL variant (HCL-v) are recognized as separate entities with HCL-v having significantly shorter overall survival. Proteomic studies, shown to be prognostic in various forms of leukemia, have not been performed in HCL. We performed reverse phase protein array-based protein profiling with 384 antibodies in HCL-c (n = 12), HCL-v (n = 4), and normal B-cells (n = 5) samples. While HCL could be distinguished from normal based on unsupervised hierarchical clustering, overlap in protein expression patterns was seen between HCL-c and HCL-v, with similar to 10% of the proteins being differentially expressed, suggesting potential therapeutic targets.
引用
收藏
页码:1321 / 1325
页数:5
相关论文
共 50 条
  • [31] Reverse Phase Protein Assay (RPPA) Defines Specific Patterns in Childhood Acute Lymphoblastic Leukemia (ALL)
    Tumino, Manuela
    Accordi, Benedetta
    Sciro, Manuela
    Giordan, Marco
    te Kronnie, Geertruy
    Basso, Giuseppe
    Lo Nigro, Luca
    BLOOD, 2008, 112 (11) : 871 - 871
  • [32] Application of Reverse Phase Protein Lysate Array (RPPA) to Formalin-Fixed, Paraffin-Embedded Tissues
    Broaddus, R.
    Xie, S-S
    Wei, C.
    Euscher, E.
    MODERN PATHOLOGY, 2011, 24 : 440A - 441A
  • [33] The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
    O'Mahony, Fiach C.
    Nanda, Jyoti
    Laird, Alexander
    Mullen, Peter
    Caldwell, Helen
    Overton, Ian M.
    Eory, Lel
    O'Donnell, Marie
    Faratian, Dana
    Powles, Thomas
    Harrison, David J.
    Stewart, Grant D.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (71):
  • [34] 2-chlorodeoxyadenosine (CDA) by subcutaneous bolus injection: A phase II study in hairy cell leukemia (HCL).
    vonRohr, A
    Bacchi, M
    Fey, MF
    Hess, U
    Tichelli, A
    Piguet, D
    Frickhofen, N
    Schirmer, M
    Wernli, M
    Zulian, G
    Marini, G
    Cerny, T
    Tobler, A
    BLOOD, 1995, 86 (10) : 1386 - 1386
  • [35] Reverse-phase protein array (RPPA) profiling of non-small cell lung cancer lines identifies tumor signatures for sensitivity and resistance to chemotherapy and targeted agents
    Averett, Lauren Byers
    Nanjundan, Meera
    Girard, Luc
    Coombes, Kevin R.
    Xie, Yang
    Peyton, Michael
    Ma, Yao
    Zachariah, Sunny
    Nikolinakos, Petros
    Cigarroa, Ricardo
    Mills, Gordon B.
    Roth, Jack A.
    Minna, John D.
    Heymach, John V.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3490S - 3490S
  • [36] Whole Genome Sequencing in Hairy Cell Leukemia-Variant (HCL-v) and Splenic Marginal Zone Lymphoma (SMZL)
    Haferlach, Torsten
    Nadarajah, Niroshan
    Meggendorfer, Manja
    Haferlach, Claudia
    Kern, Wolfgang
    BLOOD, 2017, 130
  • [37] Phase II study of rituximab in the treatment of cladribine-failed patients (pts.) with hairy cell leukemia (HCL).
    Nieva, J
    Bethel, K
    Baker, T
    Saven, A
    BLOOD, 2001, 98 (11) : 364A - 365A
  • [38] The use of reverse phase protein array (RPPA) to identify new tumor vulnerability and actionable drug targets against human cancer cell lines
    Howell, Andrew
    Wulfkhule, Julia
    Gallagher, Rosa
    Baker, Jonathan
    Hannah, Ashleigh
    Petricoin, Emanuel F.
    Tang, Amy H.
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Application of Reverse Phase Protein Lysate Array (RPPA) to Formalin-Fixed, Paraffin-Embedded Tissues.
    Broaddas, R.
    Xie, S-S
    Wei, C.
    Euscher, E.
    LABORATORY INVESTIGATION, 2011, 91 : 440A - 441A
  • [40] Efficacy and Safety of Obinutuzumab in Relapsed or Refractory Hairy Cell Leukemia (R/R HCL): An Italian Multicenter Phase-2 Academic Trial (HCL-PG04)
    Tiacci, Enrico
    De Carolis, Luca
    Capponi, Monia
    Falcinelli, Flavio
    Zaja, Francesco
    Pulsoni, Alessandro
    Simonetti, Edoardo
    Montechiarello, Elisa
    Romano, Alessandra
    Olivieri, Jacopo
    Mancini, Alessandro
    D'Elia, Gianna Maria
    Foa, Robin
    Frezzato, Maurizio
    Falini, Brunangelo
    BLOOD, 2023, 142